Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
12.24
-0.24 (-1.92%)
Dec 3, 2024, 2:09 PM EST - Market open
Roivant Sciences Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Roivant Sciences stock have an average target of 17.93, with a low estimate of 12.5 and a high estimate of 23. The average target predicts an increase of 46.49% from the current stock price of 12.24.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ROIV stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 5 | 4 |
Buy | 4 | 4 | 4 | 4 | 4 | 3 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 10 | 10 | 10 | 10 | 10 | 8 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +47.06% | Nov 13, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 19, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +47.06% | Sep 19, 2024 |
B of A Securities | B of A Securities | Hold Maintains $12 → $13 | Hold | Maintains | $12 → $13 | +2.12% | Sep 11, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +47.06% | Sep 11, 2024 |
Financial Forecast
Revenue This Year
164.58M
from 124.80M
Increased by 31.88%
Revenue Next Year
115.07M
from 164.58M
Decreased by -30.08%
EPS This Year
-0.76
from 5.23
EPS Next Year
-1.18
from -0.76
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 314.5M | 298.4M | 603.4M | ||
Avg | 164.6M | 115.1M | 204.3M | ||
Low | 108.8M | 23.5M | 23.5M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 152.0% | 81.3% | 424.4% | ||
Avg | 31.9% | -30.1% | 77.5% | ||
Low | -12.8% | -85.7% | -79.6% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.59 | -0.89 | -0.92 | ||
Avg | -0.76 | -1.18 | -1.19 | ||
Low | -0.89 | -1.67 | -1.56 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.